Evidence map›Paper›PMID 39201996›Full record

ArticleJournal of personalized medicine2024

PyCaret for Predicting Type 2 Diabetes: A Phenotype- and Gender-Based Approach with the "Nurses' Health Study" and the "Health Professionals' Follow-Up Study" Datasets.

Sebnem Gul, Kubilay Ayturan, Fırat Hardalaç

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sebnem GulDepartment of Electrical and Electronics Engineering, Faculty of Engineering, Graduate School of Natural and Applied Sciences, Gazi University, Ankara 06570, Turkey.ORCID 0000-0002-0047-7613
Kubilay AyturanDepartment of Electrical and Electronics Engineering, Faculty of Engineering, Graduate School of Natural and Applied Sciences, Gazi University, Ankara 06570, Turkey.ORCID 0000-0001-9406-4694
Fırat HardalaçDepartment of Electrical and Electronics Engineering, Faculty of Engineering, Graduate School of Natural and Applied Sciences, Gazi University, Ankara 06570, Turkey.ORCID 0000-0003-1358-0756

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting type 2 diabetes mellitus (T2DM) by using phenotypic data with machine learning (ML) techniques has received significant attention in recent years. PyCaret, a low-code automated ML tool that enables the simultaneous application of 16 different algorithms, was used to predict T2DM by using phenotypic variables from the "Nurses' Health Study" and "Health Professionals' Follow-up Study" datasets. Ridge Classifier, Linear Discriminant Analysis, and Logistic Regression (LR) were the best-performing models for the male-only data subset. For the female-only data subset, LR, Gradient Boosting Classifier, and CatBoost Classifier were the strongest models. The AUC, accuracy, and precision were approximately 0.77, 0.70, and 0.70 for males and 0.79, 0.70, and 0.71 for females, respectively. The feature importance plot showed that family history of diabetes (famdb), never having smoked, and high blood pressure (hbp) were the most influential features in females, while famdb, hbp, and currently being a smoker were the major variables in males. In conclusion, PyCaret was used successfully for the prediction of T2DM by simplifying complex ML tasks. Gender differences are important to consider for T2DM prediction. Despite this comprehensive ML tool, phenotypic variables alone may not be sufficient for early T2DM prediction; genotypic variables could also be used in combination for future studies.

Indexed as

feature importance plotmachine learningpredictionPyCaretSHAP valuetype 2 diabetes mellitus

Identifiers

PMID39201996
PMCPMC11355927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.